ETFs
N
NVO
Novo-Nordisk A/S
40.52
-0.41-1.00%After Hours: 40.65 +0.13 +0.31%19:59 04/17 EDT
OPEN/PREV CLOSE40.98/40.93
TODAY RANGE40.43-41.29
VOL13.20M
MARKET CAP179.87B
52 WEEK RANGE34.64-77.81
AVG VOL (3M)22.53M
% TURNOVER0.30%
TURNOVER--
P/E (TTM)11.20
% RANGE2.09%
EPS(TTM)3.618
P/E(FORWARD)9.07
P/B5.91
BVPS6.86
DIVIDEND1.802
P/S3.709
BETA--
DIV YIELD4.45%
FREE FLOAT MKT CAP179.86B
SHARES OUTSTANDING4.44B
NEXT EARNINGS--
FREE FLOAT4.44B
LOT SIZE1
EX-DATE03/30/2026
News
Press Releases
Financial Reports
Profile
Benzinga·29m ago
Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis'
The Motley Fool·10h ago
This Drug Stock Has Crushed the S&P 500 Over the Last Decade
TipRanks·18h ago
Novo Nordisk’s Surprise Rebound: Value, Dividends and AI
Benzinga·1d ago
Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race
Seeking Alpha·1d ago
Novo obesity drug outperforms Lilly’s in preserving lean body mass: study
Seeking Alpha·1d ago
Lilly weight loss pill prescriptions said to near 1,400 in first week of launch
Reuters·1d ago
Lilly's Foundayo hits 1,390 prescriptions in debut week
Reuters·2d ago
EUROPE RESEARCH ROUNDUP-Aperam, Engie, Standard Life
Simply Wall St·2d ago
Assessing Novo Nordisk’s (NYSE:NVO) Valuation After Recent Share Price Swings
Same Industry
Name/Symbol
Change%
Price